Objective To evaluate the efficacy of transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. MethodsLiterature from The Cochrane Library, PubMed, EMbase, Cochrane Controlled Trials Registry, ClinicalTrials.gov and China Biomedical Literature Database from January 2002 to May 2021 were searched by computer. The literature on TAVI or transcatheter aortic valve replacement treatment for simple aortic reflux were collected. Two reviewers independently screened the literature according to the inclusion and exclusion criteria, extracted data, and assessed the quality of the literature. Meta-analysis was performed using STATA 14.0 software. ResultsA total of 15 studies including 1 394 patients were included. The Newcastle-Ottawa Scales of the studies were≥6 points. The success rate of prosthetic valve implantation was 72.0%-100.0%, and there was no report of serious complications such as surgical death, myocardial infarction, and valve annulus rupture. The 30-day all-cause mortality rate was 6.3% [95%CI (3.4%, 9.1%)]. The incidence of stroke within 30 days and the rate of postoperative permanent pacemaker implantation were 2.0% [95%CI (1.0%, 4.0%)] and 6.0% [95%CI (4.0%, 10.0%)], respectively, and were both within acceptable limits. ConclusionFor patients with simple high-risk aortic regurgitation, TAVI can obtain satisfactory treatment effects and has low postoperative complications rate, and it may be a potential treatment option for such patients.
ObjectiveTo evaluate the efficacy of bipolar radiofrequency ablation procedure for atrial fibrillation (AF) during the open-heart surgery. MethodsWe retrospectively analyzed the clinical data of 137 heart disease patients combined with AF (21 patients combined with left atrial thrombus) who underwent one-stage operation of open-heart surgery and bipolar radiofrequency ablation from May 2009 to June 2014. There were 61 males and 76 females at age of 35-73(48.3±11.6)years. The patients received amiodarone treatment for 6 months after surgery and regular follow-up. The sinus rhythm conversion rate, cardiac function before and after operation, survival rate after operation, the incidence of thromboembolism and other complications were recorded. ResultsThe average cardiopulmonary bypass time during operation was 122±38 min, the average aortic crossclamp time was 78±22 min, and the average radiofrequency ablation time was 20±4 min. The atrial fibrillation was successfully ablated in 130 patients on the same day of surgery with conversion rate of 94.9%. The atrial fibrillation was converted to sinus rhythm in 114 patients, and converted to junctional cardiac arrhythmia in 16 patients. Two patients died during the perioperative period with death rate of 1.5% in hospital. The conversion rate was 81.5% (110/135), 88.1% (111/126), 83.1% (74/89), and 83.0% (39/47) respectively at one month, six months, one year, and two years after surgery, respectively. The survival rate was 96.6% (86/89) and 93.6% (44/47) at one year and two years after surgery. No thromboembolism occurred during the long-term follow-up period. ConclusionBipolar radiofrequency ablation procedure selectively performed during open-heart surgery can cure atrial fibrillation, only increases cardiopulmonary bypass and aortic crossclamp time slightly. The short- and mid-term efficacy is satisfactory with high conversion rate of sinus rhythm. The long-term effect still needs further observation.